Osimertinib Active Not Recruiting Phase 1 Trials for Advanced Non Small Cell Lung Cancer / Advanced (Inoperable) Non Small Cell Lung Cancer Other

IndicationsStatusPurposePhase
Active Not RecruitingOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT02163733Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer
NCT02157883Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)